115 related articles for article (PubMed ID: 6161957)
21. Immunohistochemistry of hepatocellular carcinoma associated with cirrhosis.
Espinoza CG; Pillarisetti SG; Azar HA
Ann Clin Lab Sci; 1984; 14(6):467-73. PubMed ID: 6210034
[TBL] [Abstract][Full Text] [Related]
22. [Immunohistochemical studies on the association between hepatitis B surface antigen and primary hepatocellular carcinoma (author's transl)].
Volc-Platzer B; Hanak H; Weiss W; Denk H
Wien Klin Wochenschr; 1982 Feb; 94(4):108-14. PubMed ID: 6281995
[TBL] [Abstract][Full Text] [Related]
23. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
24. Effect of human leukocyte interferon on HBsAg production in PLC/PRF/5 human hepatoma cell line.
Hajnická V; Stancek D
Acta Virol; 1987 Sep; 31(5):404-9. PubMed ID: 2891279
[TBL] [Abstract][Full Text] [Related]
25. [Effects of extracts from Phyllanthus urinaria L. on HBsAg production in PLC/PRF/5 cell line].
Ji XH; Qin YZ; Wang WY; Zhu JY; Liu XT
Zhongguo Zhong Yao Za Zhi; 1993 Aug; 18(8):496-8, 511. PubMed ID: 8011099
[TBL] [Abstract][Full Text] [Related]
26. [Solid tumours of human primary hepatocellular carcinoma cell-lines in hypothymic mice: a model for biochemical and therapeutic studies (author's transl)].
Hahn EG; Gauss-Müller V; Hornberger M; Kalbfleisch H; Deinhardt F
Z Gastroenterol; 1982 Mar; 20(3):168-73. PubMed ID: 6177113
[TBL] [Abstract][Full Text] [Related]
27. Establishment of a human hepatocellular carcinoma cell line releasing hepatitis B virus surface antigen.
Das PK; Nayak NC; Tsiquaye KN; Zuckerman AJ
Br J Exp Pathol; 1980 Dec; 61(6):648-54. PubMed ID: 6257270
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
Okuda H; Obata H; Motoike Y; Hisamitsu T
Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus surface and core antigens in the liver of primary hepatocellular carcinoma cases in Virginia.
Swenson PD; Escobar MR; Silverman JF
Acta Biol Acad Sci Hung; 1980; 31(1-3):321-8. PubMed ID: 6261496
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxicity by NK-like cells from hepatitis B-immune patients to a human hepatoma cell line secreting HBsAg.
Chin TW; Hollinger FB; Rich RR; Troisi CL; Dreesman GR; Melnick JL
J Immunol; 1983 Jan; 130(1):173-80. PubMed ID: 6292302
[No Abstract] [Full Text] [Related]
32. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.
Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G
Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926
[TBL] [Abstract][Full Text] [Related]
33. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
[TBL] [Abstract][Full Text] [Related]
34. Hepatic preneoplasia in hepatitis B virus transgenic mice.
Toshkov I; Chisari FV; Bannasch P
Hepatology; 1994 Nov; 20(5):1162-72. PubMed ID: 7927248
[TBL] [Abstract][Full Text] [Related]
35. Target cell populations in virus-associated hepatocarcinogenesis.
Thorgeirsson SS
Princess Takamatsu Symp; 1995; 25():163-70. PubMed ID: 8875621
[TBL] [Abstract][Full Text] [Related]
36. Establishment and serial quantification of intrahepatic xenografts of human hepatocellular carcinoma in severe combined immunodeficiency mice, and development of therapeutic strategies to overcome multidrug resistance.
Leveille-Webster CR; Arias IA
Clin Cancer Res; 1996 Apr; 2(4):695-706. PubMed ID: 9816220
[TBL] [Abstract][Full Text] [Related]
37. Orcein-positive hepatitis B surface antigen and liver carcinoma: their association in an Eastern US population.
Keshgegian AA; Ochs RH
Arch Pathol Lab Med; 1981 Apr; 105(4):190-3. PubMed ID: 6163416
[TBL] [Abstract][Full Text] [Related]
38. Human embryonic liver cell differentiation. I. Changes in specific mRNA synthesis correlates with parameters signaling oncologic alterations.
Hakim AA; Siraki CM; Dube VE
Exp Cell Biol; 1986; 54(5-6):319-32. PubMed ID: 2433170
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B surface antigen containing immune complexes occur in seronegative hepatocellular carcinoma patients.
Brown SE; Howard CR; Steward MW; Ajdukiewicz AB; Whittle HC
Clin Exp Immunol; 1984 Feb; 55(2):355-9. PubMed ID: 6199140
[TBL] [Abstract][Full Text] [Related]
40. Elevated expression of bisecting N-acetylglucosaminyltransferase-III gene in a human fetal hepatocyte cell line by hepatitis B virus.
Shim JK; Lee YC; Chung TH; Kim CH
J Gastroenterol Hepatol; 2004 Dec; 19(12):1374-87. PubMed ID: 15610311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
